Work

211 Phase II trial of sorafenib (BAY 43-9006) in malignant mesothelioma: CALGB 30307

Year: 2006

Type: article

Source: Lung Cancer

DOI: 10.1016/s0169-5002(07)70287-8

Authors: P.A. Jänne, X.F. Wang, L.M. Krug, L. Hodgson, E.E. Vokes, H.L. Kindler

Language: German

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2039540087

FWCI: 2.147

Cites:

Cited by: 11

Related to: 10